[Development and application of monoclonal antibodies against human free prostate specific antigen(f-PSA)].
Objective Construction of monoclonal antibody cell lines against human free prostate specific antigen (f-PSA), and establish double antibody sandwich CLIA for human f-PSA. Methods Two hybridoma cell lines secreting anti-f-PSA mAb were obtained by hybridoma technique. The cell lines were expanded by spinner bottles and purified by affinity purification, from which the antibodies were tested for antibody titers, specificity, epitopes by ELISA and affinity by surface plasmon resonance. Establishment, analysis and performance evaluation of a double mAbs sandwich CLIA system using standard curve quantitative method. In total 426 (130 gray area) clinical specimens were used for system comparison between our assay and Roche f-PSA assay. Results anti- f-PSA(f-10-1, f-14-1) mAbs were obtained. The CLIA system with detection range of 0.1-30 ng/mL, sensitivity of 0.05 ng/mL, relative detection deviation of ±5% and not cross-react with the tumor marker AFP, CEA and c-PSA. The correlation coefficient of our reagent with Roche's was 0.99. The positive coincidence rate, negative coincidence rate and total coincidence rate of gray area specimens were all higher than 90%. Conclusion mAbs against human f-PSA were successfully prepared, and the double mAbs sandwich CLIA for specific quantitative detection of human f-PSA was established.